Madrigal pharmaceuticals provides corporate updates and reports second quarter 2023 financial results

Conshohocken, pa., aug. 08, 2023 (globe newswire) -- madrigal pharmaceuticals, inc. (nasdaq:mdgl), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (nash), today provides a summary of recent corporate accomplishments and reports second quarter 2023 financial results.
MDGL Ratings Summary
MDGL Quant Ranking